Controversy Over Federal Funding Cuts to mRNA Vaccine Research
TL;DR Summary
Federal cuts of about $500 million to mRNA vaccine development are impacting Vermont's biotech industry, particularly Vernal Biosciences, and raising concerns about future pandemic preparedness and scientific innovation, despite the proven safety and efficacy of mRNA vaccines like those used for COVID-19.
- How federal cuts to mRNA vaccine development will affect Vermont VTDigger
- Opinion | Jay Bhattacharya: Why the NIH is pivoting away from mRNA vaccines The Washington Post
- Opinion | Robert F. Kennedy Jr.’s Impact So Far: ‘The Worst Possible Case’ The New York Times
- Trump previously called mRNA vaccines a 'medical miracle.' Now, RFK Jr. cut $500M in funding ABC News
- Commentary: RFK Jr.'s cancellation of mRNA vaccine research is even worse than it first seemed Los Angeles Times
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
4 min
vs 5 min read
Condensed
95%
844 → 42 words
Want the full story? Read the original article
Read on VTDigger